|
OPB-201 Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 1: 1
Top Sponsors
- Outpace Bio, Inc.1
Indications
- Endometrial Cancers1
- Advanced Endometrial Cancer1
- Endometrial Cancer Recurrent1
- Ovarian Cancer Recurrent1
- Platinum-resistant Ovarian Cancer1
San Francisco, California1 trial
A Phase 1 Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
UCSF - Helen Diller Family Comprehensive Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.